Cartesian Therapeutics, Inc. - Common Stock (RNAC)

CUSIP: 816212302

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
26,621,699
Total 13F shares
6,582,077
Share change
-39,341
Total reported value
$86,710,172
Price per share
$13.18
Number of holders
68
Value change
-$755,346
Number of buys
30
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 816212302?
CUSIP 816212302 identifies RNAC - Cartesian Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cartesian Therapeutics, Inc. - Common Stock (RNAC) as of Q1 2025

As of 31 Mar 2025, Cartesian Therapeutics, Inc. - Common Stock (RNAC) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,582,077 shares. The largest 10 holders included FMR LLC, MPM BIOIMPACT LLC, BlackRock, Inc., Siren, L.L.C., VANGUARD GROUP INC, Erste Asset Management GmbH, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, JPMORGAN CHASE & CO, and 683 Capital Management, LLC. This page lists 68 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.